Imatinib Completed Phase 2 Trials for Renal Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00331409Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer